Is Coral Laboratories Ltd debt-free?

Yes, Coral Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.02.

Home

Coral Laboratories Ltd

Coral Laboratories Ltd Financials

Coral Laboratories Ltd Financial Statement

Coral Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2025	Jun 2025	Mar 2025
Revenue	22.07	20.87	30.62
Operating Expense	14.10	16.64	26.22
Net Profit	5.82	2.56	2.83
Net Profit Margin	26.37	12.27	9.24
Earning Per Share	16.29	7.18	7.91
EBIDTA	7.96	4.22	4.48
Effective Tax Rate	19.95	27.19	25

Particulars	Sep 2025
Revenue	22.07
Operating Expense	14.10
Net Profit	5.82
Net Profit Margin	26.37
Earning Per Share	16.29
EBIDTA	7.96
Effective Tax Rate	19.95

Coral Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Total Revenue Annual	115.01	83.66	78.12
Operating Expenses Annual	88.77	67.42	74.31
Operating Profit Annual	34.58	22.71	10.74
Interest Annual	0.10	0.00	0.34
Depreciation	2.00	1.97	2.17
Net Profit Annual	24.16	15.79	6.45
Tax Annual	8.31	4.94	1.78

Particulars	Mar 2025
Total Revenue Annual	115.01
Operating Expenses Annual	88.77
Operating Profit Annual	34.58
Interest Annual	0.10
Depreciation	2.00
Net Profit Annual	24.16
Tax Annual	8.31

Coral Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Cash Flow at the Beginning	2.07	6.13	2.51
Cash Flow from Operations	-1.22	-5.46	12.67
Cash Flow from Investing	-0.15	1.40	-2.61
Cash Flow from Financing	2.71	0.01	-6.43
Cash Flow at the End	3.41	2.07	6.13

Particulars	Mar 2025
Cash Flow at the Beginning	2.07
Cash Flow from Operations	-1.22
Cash Flow from Investing	-0.15
Cash Flow from Financing	2.71
Cash Flow at the End	3.41

Coral Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
PBDIT Margin (%)	30.07	27.15	13.76
PBIT Margin (%)	28.32	24.78	10.97
PBT Margin (%)	-254.87	24.78	-21.30
Net PROFIT Margin (%)	21.01	18.87	8.26
Return On Networth / Equity (%)	12.76	9.50	4.15
Return On Networth /Employed (%)	16.98	12.26	5.23
Return On Assets (%)	12.60	9.25	3.96
Total Debt / Equity (X)	0.01	TBA	0.02
Asset Turnover Ratio (%)	0.60	0.49	0.48

Particulars	Mar 2025
PBDIT Margin (%)	30.07
PBIT Margin (%)	28.32
PBT Margin (%)	-254.87
Net PROFIT Margin (%)	21.01
Return On Networth / Equity (%)	12.76
Return On Networth /Employed (%)	16.98
Return On Assets (%)	12.60
Total Debt / Equity (X)	0.01
Asset Turnover Ratio (%)	0.60

Coral Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Fixed Assets Annual	21.81	23.34	24.30
Total Current Assets Annual	176.55	153.85	123.54
Non Current Assets Annual	52.92	51.83	50.81
Total Shareholders Funds Annual	201.21	177.50	154.80
Total Assets Annual	229.46	205.68	174.35

Particulars	Mar 2025
Fixed Assets Annual	21.81
Total Current Assets Annual	176.55
Non Current Assets Annual	52.92
Total Shareholders Funds Annual	201.21
Total Assets Annual	229.46

Coral Laboratories Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Coral Laboratories Ltd Financials

As of Dec 5, 2025, Coral Laboratories Ltd has a market capitalization of 250.40 Cr. Value Research classifies it as a Small-Cap company.

Yes, Coral Laboratories Ltd is with a debt-to-equity ratio of 0.02.

In FY 2024 , Coral Laboratories Ltd recorded a total revenue of approximately 115.01 Cr marking a significant milestone in the company's financial performance.

Coral Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.6% and 0.2% annually, respectively..

Coral Laboratories Ltd's current PE ratio is 10.36.

Coral Laboratories Ltd's ROCE averaged 11.0% from the FY ending March 2023 to 2025, with a median of 11.7%. It peaked at 15.9% in March 2025, reflecting strong capital efficiency over the period..

Coral Laboratories Ltd's latest EBIT is Rs. 32.57 Cr, surpassing the average EBIT of Rs. 20.62 Cr over the 5 years..